Crossover Designs in Biomarker-Driven Oncology Trials
Crossover Designs in Biomarker-Driven Oncology Trials Implementing Crossover Designs for Biomarker-Driven Oncology Studies Introduction to Crossover Designs in Oncology Crossover designs in biomarker-driven oncology trials allow patients to switch from the control arm to the experimental treatment (or vice versa) after certain conditions are met—often upon disease progression. These designs are particularly valuable in targeted…
Read More “Crossover Designs in Biomarker-Driven Oncology Trials” »